Jurgen T. Rohr,Daniel Scott,Markos Leggas,Jhong-Min Chen,Oleg V. Tsodikov
申请号：
US14717542
公开号：
US09447135B2
申请日:
2015.05.20
申请国别(地区):
US
年份:
2016
代理人:
摘要：
Mithramycin derivatives and their pharmaceutically acceptable salts are disclosed. The mithramycin derivatives can be used in the treatment of Ewing sarcoma or other cancer or neuro-disease associated with an aberrant erythroblast transformation-specific transcription factor.
